ARCHIVES

Early HER2 Positive Patients At Higher Risk of Recurrence

This article is from The Cancer Letter archive.

Vol. 32 No. 1 | January 30, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Scientists May Run For Congress; Upton Back Heroin For Terminal Cancer Patients

September 9, 1977

New SEER RFP Sees cheaper Way To Get Data

July 29, 1977

Low Total Cholesterol Linked To Higher Risk Of Cancer; Higher HDL Associated With Decreased Risk Of Cancer

November 27, 2009

New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial

May 30, 2014

NCI’s Otis Brawley Named Professor At Emory, Associate Director, Cancer Control, At Winship.

April 20, 2001

New Reagan Budget Or FY 1982 gives NCI $1.026 Billion

March 6, 1981